Exogenous AAS inhibit endogenous testosterone production, and discontinuation of their use is often associated with a prolonged decrease in testosterone secretion (Kanayama et al., 2015
A one-size-fits-all approach doesnt work when it comes to weight loss assisted by GLP-1 drugs
The same goes for refills
One such option is Mounjaro (tirzepatide), a once-weekly injectable medication that was originally approved for type 2 diabetes and is now FDA-approved for weight management in adults with obesity or overweight and at least one weight-related health condition
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test analyzes four key peptide-pathway variantsGLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313to provide context about individual predispositions in GLP-1 signaling and weight regulation
The medication ships to your door from a local third-party tested pharmacy